(NF019)
Herpes zoster (commonly called "shingles") results from reactivation of the varicella-zoster virus (VZV) acquired during a primary varicella infection (chickenpox). Primary VZV infection occurs when a susceptible individual (usually a child) is exposed to airborne virus via a respiratory route. Over 90% of adults in the United States have evidence of prior VZV infection on blood testing.
While zoster can erupt on almost any part of the body, the most common areas are the face and the torso. The characteristic rash of herpes zoster is often preceded by a prodrome of burning pain, itching or sensitivity of the affected area.
The skin lesions begin as a red, raised rash that follows a dermatomal distribution. The rash evolves into small fluid-filled blisters (vesicles) on a reddened base. The vesicles are generally painful, and their development is often associated with the occurrence of flu-like symptoms and anxiety. The vesicles eventually become cloudy and may bleed. Within 7-10 days, the vesicles crust over. As these crusts fall off, scarring and changes in skin color may remain.
While medications do not cure zoster infections, they have been found to help shorten the duration and discomfort of the outbreak. Perhaps more importantly, antiviral medications have been found to help reduce or prevent the occurrence of postherpetic neuralgia pain.
The Medifocus Guide on Shingles provides answers to the following important questions and medical issues:
- What are the most common symptoms of shingles?
- Are there any recognized risk factors for developing shingles?
- What kinds of medical tests are used to establish the diagnosis of shingles?
- What is the current standard of care for the treatment of shingles?
- What treatment options are available for the management of shingles?
- Are there any promising new developments or potential breakthroughs in treatment?
- Who are the most notable medical authorities who specialize in shingles?
- Where are the leading hospitals and centers of research for shingles?
- What are the most important questions to ask my doctor about shingles?
This MediFocus Guide contains an extensive listing of citations and abstracts of recent journal articles that have been published about this condition in trustworthy medical journals. This is the same type of information that is available to physicians and other health care professionals. Click Medifocus
- Zoster paresis of the shoulder. Case report and review of the literature.
Clinical Orthopaedics & Related Research. 2000 - The role of sympathetic nerve blocks in herpes zoster and postherpetic neuralgia.
Pain. 2000 - Acute and chronic herpes zoster. An ancient scourge yields to timely therapy.
Postgraduate Medicine. 2000 - Valaciclovir: a review of its use in the management of herpes zoster.
Drugs. 2000 - Varicella-Zoster virus: pathogenesis, immunity, and clinical management in hematopoietic cell transplant recipients.
Biology of Blood & Marrow Transplantation. 2000 - Prospects for the prevention of postherpetic neuralgia in herpes zoster patients.
Clinical Journal of Pain. 2000 - Treatment of postherpetic neuralgia: an update.
Drugs. 2000 - Management of herpes zoster (shingles) and postherpetic neuralgia.
American Family Physician. 2000 - Does treatment of acute herpes zoster prevent or shorten postherpetic neuralgia?.
Journal of Family Practice. 2000 - Neurologic complications of the reactivation of varicella-zoster virus.
New England Journal of Medicine. 2000
